Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| MZL | 2 | 0 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 2
New Tier 1, MZL Tier 1, 2
This study, New Tier 2, 0
New Tier 2, MZL Tier 2, 0
This study, New Tier 3, 0
New Tier 3, MZL Tier 3, 0
All other MZL studies, MZL Tier 1, 40
All other MZL studies, MZL Tier 2, 74
All other MZL studies, MZL Tier 3, 0
Novel genes reported in this study
Tier 1
| New gene | MZL tier |
|---|---|
| CARD11 | 1 |
| MYD88 | 1 |
Details
Yan, Qingguo, Yuanxue Huang, A. James Watkins, Sylvia Kocialkowski,
Naiyan Zeng, Rifat A. Hamoudi, Peter G. Isaacson, Laurence de Leval,
Andrew Wotherspoon, and Ming-Qing Du. 2012. “BCR and
TLR Signaling Pathways Are Recurrently Targeted by Genetic
Changes in Splenic Marginal Zone Lymphomas.”
Haematologica 97 (4): 595–98. https://doi.org/10.3324/haematol.2011.054080.


